What Will Drug Development Look Like in 2036?
Members of The Medicine Maker’s 2026 Power List predict how AI, new modalities, integrated data, and shifting global markets will reshape the industry
-
1
The distinction between small molecules and biologics will diminish, with new technologies targeting previously inaccessible disease mechanisms.
-
2
AI will transform drug development by enhancing efficiency in target identification, clinical trial design, and patient recruitment.
-
3
Drug development will become more integrated and data-driven, utilizing real-time learning systems and digital twins for predictive design.
-
4
The majority of early-stage drug development is expected to shift to Asia due to more efficient operational models.
-
5
Regulatory review times are anticipated to decrease by 30%, improving the prediction of drug efficacy using real-world evidence.
